P G Vlachoyiannopoulos - JoVE Visualize

Showing results (21-30 of 55) with videos related to

Pageof 6

Sort By:

Annals of the Rheumatic Diseases|October 1, 1996

Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosisP G Vlachoyiannopoulos, N Tsifetaki, I Dimitriou, et al.

European Journal of Clinical Investigation|July 25, 2000

Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestationsM G Tektonidou, C A Petrovas, J P Ioannidis, et al.

QJM : Monthly Journal of the Association of Physicians|August 5, 2000

Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndromeM G Tektonidou, J P Ioannidis, K A Boki, et al.

Lupus|October 1, 1993

Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patientsP G Vlachoyiannopoulos, F B Karassa, K X Karakostas, et al.

The Journal of Rheumatology|January 1, 1991

D-penicillamine toxicity in Greek patients with rheumatoid arthritis: anti-Ro(SSA) antibodies and cryoglobulinemia are predictive factorsP G Vlachoyiannopoulos, L V Zerva, F N Skopouli, et al.

Clinical Immunology and Immunopathology|November 1, 1989

Circulating antibodies to prothymosin alpha in systemic lupus erythematosusP G Vlachoyiannopoulos, S Frillingos, A G Tzioufas, et al.

The Journal of Rheumatology|August 26, 1998

Hypofunction of the stress axis in Sjögren's syndromeE O Johnson, P G Vlachoyiannopoulos, F N Skopouli, et al.

Journal of Autoimmunity|April 1, 1994

Autoantibodies to HMG-17 nucleosomal protein in patients with sclerodermaP G Vlachoyiannopoulos, V A Boumba, A G Tzioufas, et al.

European Journal of Clinical Investigation|November 28, 1997

Evidence for non-adaptive immune response in HIV infectionV Tzavara, P G Vlachoyiannopoulos, T Kordossis, et al.

Methods (San Diego, Calif.)|October 20, 1999

Peptide carriers: A helicoid-type sequential oligopeptide carrier (SOC(n)) for multiple anchoring of antigenic/immunogenic peptidesM Sakarellos-Daitsiotis, V Tsikaris, P G Vlachoyiannopoulos, et al.

Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:

Pageof 6

Annals of the Rheumatic Diseases|October 1, 1996

Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosisP G Vlachoyiannopoulos, N Tsifetaki, I Dimitriou, et al.

European Journal of Clinical Investigation|July 25, 2000

Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestationsM G Tektonidou, C A Petrovas, J P Ioannidis, et al.

QJM : Monthly Journal of the Association of Physicians|August 5, 2000

Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndromeM G Tektonidou, J P Ioannidis, K A Boki, et al.

Lupus|October 1, 1993

Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patientsP G Vlachoyiannopoulos, F B Karassa, K X Karakostas, et al.

The Journal of Rheumatology|January 1, 1991

D-penicillamine toxicity in Greek patients with rheumatoid arthritis: anti-Ro(SSA) antibodies and cryoglobulinemia are predictive factorsP G Vlachoyiannopoulos, L V Zerva, F N Skopouli, et al.

Clinical Immunology and Immunopathology|November 1, 1989

Circulating antibodies to prothymosin alpha in systemic lupus erythematosusP G Vlachoyiannopoulos, S Frillingos, A G Tzioufas, et al.

The Journal of Rheumatology|August 26, 1998

Hypofunction of the stress axis in Sjögren's syndromeE O Johnson, P G Vlachoyiannopoulos, F N Skopouli, et al.

Journal of Autoimmunity|April 1, 1994

Autoantibodies to HMG-17 nucleosomal protein in patients with sclerodermaP G Vlachoyiannopoulos, V A Boumba, A G Tzioufas, et al.

European Journal of Clinical Investigation|November 28, 1997

Evidence for non-adaptive immune response in HIV infectionV Tzavara, P G Vlachoyiannopoulos, T Kordossis, et al.

Methods (San Diego, Calif.)|October 20, 1999

Peptide carriers: A helicoid-type sequential oligopeptide carrier (SOC(n)) for multiple anchoring of antigenic/immunogenic peptidesM Sakarellos-Daitsiotis, V Tsikaris, P G Vlachoyiannopoulos, et al.

Pageof 6